|Publication number||US3780935 A|
|Publication date||Dec 25, 1973|
|Filing date||Jul 10, 1972|
|Priority date||Jul 10, 1972|
|Also published as||DE2340199A1, DE2340199B2|
|Publication number||US 3780935 A, US 3780935A, US-A-3780935, US3780935 A, US3780935A|
|Inventors||Jacoby I, Lukacs M|
|Original Assignee||Lukacs & Jacoby Ass|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (2), Referenced by (94), Classifications (9), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent [191 Lukacs et al.
[ Dec. 25, 1973 SERUM SEPARATING METHOD Inventors: Michel J. Lukacs, Goshen, N.Y.; [an
H. Jacoby, Franklin Lakes, NJ.
Assignee: Lukacs & Jacoby Associates,
Filed: July 10, 1972 Appl. No.: 270,278
US. Cl 233/1 A, 210/65, 210/83 Int. Cl 801d 21/26 Field of Search 106/287 SB; 210/65,
210/83, DIG. 23; 233/1, 26
References Cited UNITED STATES PATENTS 3/1972 Adler ..2l0/83 4/1970 Coleman ..2lO/83 Primary Examiner-Samih N. Zahama Assistant Examiner-Robert G. Mukai Attorney.lohn A. Mitchell et al.
ABSTRACT 3 Claims, 8 Drawing Figures PATENTED M825 I975 FIG. 4
FIG. 2 FIG. 3
SERUM SEPARATING METHOD BACKGROUND OF THE INVENTION This invention relates to a method, apparatus and composition of matter for separating a blood sample by centrifuging into clot portions, so that the serum may be quickly and readily removed without contamination by the clot portion.
In recent years, biomedical and hospital laboratories have been faced with increasing demands for more and more routine, as well as specialized, diagnostic tests of blood samples. To meet the demands of these tests equipment has been devised which automatically takes a sample or specimen of blood which has been placed in a cup and subjects it to a series of programmed tests which eventuate in a readout on a record member. While these analyzers have increased the efficiency of performing the necessary tests, a problem has continued in finding ways and means of separating the serum from the clot portion and removing the serum for analysis. Various types of tube and plug devices have been suggested by the prior art. For example, in U.S. Pat. No. 3,512,940, issued May 19, 1970, a device consisting of a tube with a filter at one end thereof is inserted into a second but larger diameter tube containing a sample of the material desired to be filtered. In U.S. Pat. No. 3,508,653, issued Apr. 28, 1970, a piston in the form of a solid plug is driven through a centrifuged blood sample so as to position itself between the serum and clot portions of the centrifuged sample. The tube within the tube concept of US. Pat. No. 3,512,940 suffers from the apparent deficiency of being costly and not readily adaptable for disposal after a single use. The plug' arrangement of US. Pat. No. 3,508,653 has the shortcoming of utilizing a solid plug member which when subjected to a substantial centrifugal force, may also develop radial forces acting against the side of the sample tube, thus creating the danger of breakage.
SUMMARY OF THE INVENTION a silicone fluid and silica. The sealant has a specific gravity of at least 1.026 and preferably in the range of 1.030 to 1.050. As such, it will normally be at the proper specific gravity to divide the serum and clot portions of the centrifuged sample, sealing the clot in the container while the serum is removed.
Accordingly, it is an object of the present invention to provide a simple and effective method of obtaining a serum sample during centrifuging.
DESCRIPTION OF THE DRAWINGS FIG. 4 is a view similar to FIG. 2 wherein the blood, the sample tube and dispenser have been subjected to the complete centrifuging step;
FIG. 5 is a sectional view of the sample tube with the separator in place overlying the clot portion with the serum portion removed;
FIG. 6 is an enlarged sectional view of the sealant dispenser showing the sealant contained therein;
FIG. 7 is a top view of the dispenser of FIG. 6; and
FIG. 8 is a bottom view of the dispenser of FIG. 6.
DESCRIPTION OF THE ILLUSTRATED EMBODIMENT Referring to the drawings, a container 10 for holding a blood sample is illustrated as a straight side wall sample tube 10 with an open top end 11. Into the open top 11 is inserted a dispenser 12. The dispenser 12 has a flange member 14 which overlies the top edge 16 of the side wall 18 of the container. The dispenser 12 includes a body portion 19; consisting of three ring sections 20, 22 and 24. Extending from the body 19 is an elongated nozzle portion 26 and at the end of the nozzle 26 is a tip 28 having an opening 30 therein. The purpose of the three rings 20, 22 and 24 is to permit the dispenser 12 to be used with containers of various diameters. Ring 20 has a shoulder 32 and a side wall 33,-ring 22 a shoulder 34 and a side wall 35, and ring 24 has a shoulder 36 and a side wall 37. When using a narrow container, the dispenser bears on the top edge of the side wall of the container at one of the shoulders 32, 34 or 36 and the side wall of the next smaller ring is parallel with the inner side wall of the container. During centrifuging the relationship between the inner surface of the container and the side wall of the ring insures stability of the dispenser during this period.
By utilizing a dispenser as illustrated herein, it is possible to use one dispenser for varying diameter containers.
The body portion 19 of the dispenser has an open end 37 over which is placed a seal 38. The seal 38 has a small opening 40 therein. The seal 38 is not placed over the open end until a sealant 42 has been placed in the dispenser.
The sealant 42 consists essentially of a silicone fluid with an inert filler, such as silica, dispersed therein. The sealant should have a specific gravity of at least 1.026
. and preferably in the range of 1.030 to 1.050.
The normal specific gravity of blood as determined by the pycnometric method is considered to be in the range of 1.048 to 1.066 with averages of 1.052 to 1.063. After centrifuging the specific gravity of the blood serum which separates from the remainder of the blood is at least 1.026 and in the range of 1.026 to 1.031. The specific gravity of the heavier portions such as the erythrocytes is 1.092 to 1.095.
In selecting a sealant it is necessary to select one which has a specific gravity greater than that of the serum portion. Accordingly, the sealant should have a specific gravity of at least 1.026. However, its specific gravity should not be too high so as to cause it to layer somewhere in the clot portion. Such layering would be of no practical use towards obtaining a separated serum portion. A preferred sealant would have a specific gravity in the range of 1.030 to 1.050.
The sealant is also preferably thioxtropic, water insoluble, substantially non-toxic as well as substantially chemically inert with respect to the constituents of the blood sample, particularly those in the serum portion.
A preferred sealant formulation is as follows:
EXAMPLE I Parts by weight The silicone fluid used in Example I was a dimethylpolysiloxane polymer made by Union Carbide Corporation and identified by the designation L- 45. it had a viscosity of 12,500 centistokes and a specific gravity of about 0.973 at 25C. The silica with a specific gravity of 2.65 was an amorphous silica having a particle size of at least 75 percent being less than 5.0 microns. It was made by Whittaker, Clark & Daniels and identified by the designation No. 31 Lo Micron". The silica with a specific gravity of 2.3 was a hydrophobic amorphous silica having an average particle size of about 20 millimicrons. It was made by Degussa Inc. and identified by the designation Aerosil R 972.
The silicone fluid and the silica were mixed together to a thixotropic condition with a resultant specific gravity of 1.045 to 1.050 to form the sealant.
The sealant was then placed in a dispenser of the type illustrated in FIG. 6 in particular. The diameter of the flange was 0.70 inches and the overall length 1.75 inches with the nozzle and tip being 1.10 inches. The opening in the tip was 0.032 inches. The filled dispenser was placed in a standard sample tube having an overall length of 3.875 inches with the shoulder 32 of the first ring resting on the top of the tube side wall. The tube had previously been filled with a whole blood specimen to within 1.10 inches of the open end of the tube. The extent of the dispenser from shoulder 32 to the end of the tip was 1.5 inches. Thus, the dispenser tip and part of the nozzle extended well into the blood sample.
The tube with the blood sample and dispenser was centrifuged for approximately 10 minutes. After 5 minutes substantially all of the sealant had passed from the dispenser. The sealant did not disperse but instead remained homogeneous and settled as a layer between the serum and clot portions of the centrifuged blood. it was noted that the sealant settled as a substantially even layer between the two portions since its specific gravity of 1.045 to 1.050 was less than that of the clot portion and greater than that of the serum portion. The sealant formed a tight seal against the inner wall of the tube. Also noted was the fact, that the sealant had mixed into it, particularly in the portion near the clot portion, fibrant matter which had been filtered out of the serum portion as the sealant settled to its own specific gravity level.
The use of the dispenser which extended into the blood sample expedited the procedure since it was not necessary for the sealant to overcome the surface tension of the blood sample.
With the sealant in place it was possible to merely decant off the serum portion with the clot being trapped behind the sealant.
The specific gravity of the sealant was determined by using a copper sulfate method. The procedure consists of letting drops of the sealant fall into a graded series of solutions of copper sulfate of known specific gravity and noting whether the drops rise or fall. The series used were graded at 0.005 intervals. Merely by observing the drops it was possible to determine that the sealant had a specific gravity between 1.045 and 1.050.
Another sealant formulation is as follows:
EXAMPLE ll Parts by weight Silicone fluid (dimethylpolysiloxane) I00 Silica (specific gravity 1.95) 14 The silicone fluid of Example 11 is the same dimethylpolysiloxane polymer of Example 1. The silica with a specific gravity of 1.05 has an average particle size of 16 millimicrons. it is made by Henlig & Co. and identified by the designation TRI-SlL 404. The specific gravity is from 1.045 to 1.050.
Still another sealant formulation is as follows:
EXAMPLE Ill Parts by weight Silicone fluid (ethyltriethoxysilane) Silica (specific gravity 2.65) 8 Silica (specific gravity 2.3) 20 The silicone fluid of Example 11 is an ethyltriethoxysilane monomer made by Union Carbide Corporation and identified by the designation A-15. The silicas are the same as those used in Example I.
The filler serves the dual purpose of making the silicone fluid thixotropic and of adjusting the specific gravity to that which is desired for the resultant sealant. In place of silica other inert fillers which may be used in a fine powdered form are bentoniate, alumina and talc. Others will also occur to those skilled in the art.
Another silicone fluid which may be used is made by Dow Corning Corporation and identified as 200 Fluid.
In selecting silicone fluids and fillers, one should select materials which when mixed together will give the desired specific gravity, be substantially non-toxic, water insoluble and substantially chemically inert with respect to the constituents of at least the serum portion.
The dispenser serves to meter out the sealant gradually and this gradual metering provides sufficient lead time for the centrifugation to take effect before the sealant is in place. If the sealant were allowed to be positioned too soon some unwanted matter, such as red cells or fibrilar like material, may be trapped in the serum portion by the sealant.
While various examples have been described herein and one embodiment illustrated on the drawings, those skilled in the art may practice the invention in its various forms by other examples and embodiments without departing from the scope of the claims herein.
What is claimed is:
1. A method of separating a sample of whole blood into serum and clot portions comprising the steps of:
placing a quantity of whole blood into a container adapted to be centrifuged;
inserting into said container a supply of a thixotropic,
water insoluble, substantially non-toxic sealant consisting essentially of a silicone fluid and an inert filler dispersed therein, said sealant having a specific gravity in the range of 1.026 to 1.092; and
centrifuging the blood into serum and clot portions until the sealant forms a'separator between said portions.
2. A method as defined in claim 1 wherein the inert filler is silica.
3. A method as defined in claim 1 wherein the sealant has a specific gravity in the range of 1.030 to 1.050.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3508653 *||Nov 17, 1967||Apr 28, 1970||Charles M Coleman||Method and apparatus for fluid handling and separation|
|US3647070 *||Jun 11, 1970||Mar 7, 1972||Technicon Corp||Method and apparatus for the provision of fluid interface barriers|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3852194 *||Dec 11, 1972||Dec 3, 1974||Corning Glass Works||Apparatus and method for fluid collection and partitioning|
|US3869388 *||Jun 25, 1973||Mar 4, 1975||Continental Oil Co||Oil water separation|
|US3909419 *||Feb 27, 1974||Sep 30, 1975||Becton Dickinson Co||Plasma separator with squeezed sealant|
|US3919085 *||Feb 27, 1974||Nov 11, 1975||Becton Dickinson Co||Plasma separator assembly|
|US3920549 *||Mar 18, 1974||Nov 18, 1975||Corning Glass Works||Method and apparatus for multiphase fluid collection and separation|
|US3920557 *||Feb 27, 1974||Nov 18, 1975||Becton Dickinson Co||Serum/plasma separator--beads-plus-adhesive type|
|US3929646 *||Jul 22, 1974||Dec 30, 1975||Technicon Instr||Serum separator and fibrin filter|
|US3957653 *||Apr 3, 1975||May 18, 1976||Becton, Dickinson And Company||Apparatus for collection, separation and isolation of blood|
|US3957654 *||Jun 5, 1975||May 18, 1976||Becton, Dickinson And Company||Plasma separator with barrier to eject sealant|
|US3976579 *||Jul 10, 1975||Aug 24, 1976||Becton, Dickinson And Company||Novel assembly|
|US3977982 *||Jan 20, 1975||Aug 31, 1976||Corning Glass Works||Controlling viscosity of silica-silicone oil gels|
|US3986962 *||Jul 10, 1975||Oct 19, 1976||Becton, Dickinson And Company||Novel assembly for separating blood|
|US4001122 *||Aug 22, 1973||Jan 4, 1977||Telan Corporation||Method and device for separating blood components|
|US4018564 *||Nov 24, 1975||Apr 19, 1977||General Electric Company||Silicone composition for analyzing blood samples|
|US4021340 *||Nov 28, 1975||May 3, 1977||Corning Glass Works||Blood separating composition|
|US4043928 *||Oct 31, 1973||Aug 23, 1977||Lukacs And Jacoby Associates||Serum separating composition of matter|
|US4049692 *||Dec 16, 1974||Sep 20, 1977||Corning Glass Works||Stabilized blood separating composition|
|US4052320 *||Jul 8, 1976||Oct 4, 1977||Eastman Kodak Company||Telescoping serum separator and dispenser|
|US4055501 *||Jan 16, 1976||Oct 25, 1977||Sherwood Medical Industries Inc.||Fluid collection device with phase partitioning means|
|US4071316 *||Dec 20, 1976||Jan 31, 1978||General Electric Company||Silicone composition for analyzing blood samples|
|US4083784 *||Apr 28, 1977||Apr 11, 1978||Corning Glass Works||Stabilized blood separating composition|
|US4088582 *||Jan 16, 1976||May 9, 1978||Sherwood Medical Industries Inc.||Blood phase separation means|
|US4152269 *||Feb 1, 1977||May 1, 1979||Warner-Lambert Company||Collection and separation device|
|US4167955 *||Jun 5, 1978||Sep 18, 1979||Beckman Instruments, Inc.||Layering a liquid sample onto centrifuge tube liquid contents|
|US4189382 *||Apr 3, 1978||Feb 19, 1980||Sherwood Medical Industries Inc.||Blood coagulation and separation|
|US4190535 *||Jul 10, 1978||Feb 26, 1980||Corning Glass Works||Means for separating lymphocytes and monocytes from anticoagulated blood|
|US4235725 *||Aug 16, 1978||Nov 25, 1980||Owens-Illinois, Inc.||Sterile blood-collecting and separating device|
|US4279863 *||Sep 12, 1979||Jul 21, 1981||Sherwood Medical Industries, Inc.||Reagent separator for a blood collection tube|
|US4333564 *||Jan 16, 1980||Jun 8, 1982||Sherwood Medical Industries Inc.||Method of controlling rheological properties of gel-like compositions|
|US4350593 *||Jun 25, 1979||Sep 21, 1982||Becton, Dickinson And Company||Assembly, compositions and method for separating blood|
|US4386003 *||Sep 17, 1981||May 31, 1983||Sherwood Medical Industries Inc.||Blood separating composition|
|US4534798 *||Nov 18, 1983||Aug 13, 1985||Sekisui Kagaku Kogyo Kabushiki Kaisha||Composition for partitioning blood components|
|US4770779 *||Jul 1, 1987||Sep 13, 1988||Terumo Corporation||Apparatus for separating blood|
|US4994393 *||Feb 22, 1989||Feb 19, 1991||Becton, Dickinson And Company||Blood partitioning composition|
|US5169543 *||Mar 27, 1990||Dec 8, 1992||Nippon Paint Co., Ltd.||Serum separation sealant and fine resin particles using the same|
|US5236604 *||May 29, 1991||Aug 17, 1993||Sherwood Medical Company||Serum separation blood collection tube and the method of using thereof|
|US5266199 *||Nov 19, 1991||Nov 30, 1993||Nigata Chemicals And Plastics Co., Ltd.||Serum separating apparatus|
|US5269927 *||Dec 16, 1991||Dec 14, 1993||Sherwood Medical Company||Separation device for use in blood collection tubes|
|US5438000 *||Nov 12, 1993||Aug 1, 1995||Nippon Paint Co., Ltd.||Serum separation sealant|
|US5454958 *||Sep 1, 1993||Oct 3, 1995||Sherwood Medical Company||Method for sampling in a container having a material therein which separates from a barrier material|
|US5506333 *||Feb 16, 1995||Apr 9, 1996||Henkel Corporation||Polyesters for use in blood partitioning|
|US5968018 *||Oct 30, 1996||Oct 19, 1999||Cohesion Corporation||Cell separation device and in-line orifice mixer system|
|US5997811 *||Jul 2, 1997||Dec 7, 1999||Cohesion Technologies, Inc.||Method for sterile syringe packaging and handling|
|US6376210||Jul 6, 1999||Apr 23, 2002||General Atomics||Methods and compositions for assaying analytes|
|US6398956||May 30, 2000||Jun 4, 2002||Bio/Data Corporation||Method and apparatus for directly sampling a fluid for microfiltration|
|US6610504||Apr 10, 2000||Aug 26, 2003||General Atomics||Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase|
|US6740240||Feb 6, 2002||May 25, 2004||Bio/Data Corporation||Method and apparatus for directly sampling a fluid for microfiltration|
|US6878346||May 6, 2003||Apr 12, 2005||Bayer Corporation||Serum transfer cup|
|US6926834||May 25, 2004||Aug 9, 2005||Bio/Data Corporation||Method and apparatus for directly sampling a fluid for microfiltration|
|US7070939||Sep 26, 2001||Jul 4, 2006||The Scripps Research Institute||Methods for detecting vasculopathies and tumors|
|US7151000 *||Apr 28, 2003||Dec 19, 2006||The Regents Of The University Of California||Method of concentrating proteins from serum|
|US7192729||Jan 10, 2002||Mar 20, 2007||General Atomics||Methods for assaying homocysteine|
|US7288195||Aug 9, 2005||Oct 30, 2007||Bio/Data Corporation||Method and apparatus for directly sampling a fluid for microfiltration|
|US7384760||Apr 30, 2004||Jun 10, 2008||General Atomics||Methods for assaying inhibitors of S-adenosylhomocysteine (SAH) hydrolase and S-adenosylmethionine (SAM)-dependent methyltransferase|
|US7517694 *||Jul 24, 2003||Apr 14, 2009||Ortho-Clinical Diagnostics, Inc.||Metering tip with internal features to control fluid meniscus and oscillation|
|US7673758||Nov 1, 2007||Mar 9, 2010||The Regents Of The University Of California||Collection tubes apparatus, systems, and methods|
|US7674388||Aug 4, 2006||Mar 9, 2010||The Regents Of The University Of California||Photopolymer serum separator|
|US7766900||Sep 8, 2005||Aug 3, 2010||Biomet Manufacturing Corp.||Method and apparatus for application of a fluid|
|US7780861||Jan 21, 2010||Aug 24, 2010||The Regents Of University Of California||Photopolymer serum separator|
|US7829112||May 22, 2008||Nov 9, 2010||The General Hospital Corporation||Methods and devices for the sustained release of multiple drugs|
|US7833545||Apr 29, 2004||Nov 16, 2010||The General Hospital Corporation||Methods and devices for the sustained release of multiple drugs|
|US7838024||May 22, 2008||Nov 23, 2010||The General Hospital Corporation||Methods and devices for the sustained release of multiple drugs|
|US7883718||May 22, 2008||Feb 8, 2011||The General Hospital Corporation||Methods and devices for the sustained release of multiple drugs|
|US7971730||Nov 14, 2008||Jul 5, 2011||The Regents Of The University Of California||Collection tubes apparatus, systems and methods|
|US8151996||Aug 23, 2010||Apr 10, 2012||The Regents Of The University Of California||Photopolymer serum separator|
|US8182769||Apr 4, 2008||May 22, 2012||Biomet Biologics, Llc||Clean transportation system|
|US8206638||Jan 21, 2010||Jun 26, 2012||The Regents Of The University Of California||Collection tubes apparatus, systems, and methods|
|US8318077 *||May 29, 2012||Nov 27, 2012||The Regents Of The University Of California||Collection tubes apparatus, systems, and methods|
|US8377395||Apr 29, 2011||Feb 19, 2013||Charles M. Coleman||Integrated blood specimen processor|
|US8394342||Jul 21, 2009||Mar 12, 2013||Becton, Dickinson And Company||Density phase separation device|
|US8444620||Jul 8, 2010||May 21, 2013||Biomet Biologics, Llc||Method and apparatus for application of a fluid|
|US8475742 *||Nov 9, 2009||Jul 2, 2013||Hitachi Chemical Co., Ltd.||Blood serum or blood plasma separating material and blood-collecting tube using same|
|US8518272||Apr 4, 2008||Aug 27, 2013||Biomet Biologics, Llc||Sterile blood separating system|
|US8580183||Nov 19, 2012||Nov 12, 2013||The Regents Of The University Of California||Collection tubes apparatus, systems, and methods|
|US8747781||Jul 21, 2009||Jun 10, 2014||Becton, Dickinson And Company||Density phase separation device|
|US8794452||Aug 1, 2013||Aug 5, 2014||Becton, Dickinson And Company||Density phase separation device|
|US8936162||Jul 1, 2011||Jan 20, 2015||The Regents Of The University Of California||Collection tubes apparatus, systems and methods|
|US8998000||May 14, 2010||Apr 7, 2015||Becton, Dickinson And Company||Density phase separation device|
|US9028457||May 21, 2013||May 12, 2015||Biomet Biologics, Llc||Method and apparatus for application of a fluid|
|US9079123||Aug 6, 2013||Jul 14, 2015||Becton, Dickinson And Company||Density phase separation device|
|US20040072367 *||Jul 24, 2003||Apr 15, 2004||Ortho-Clinical Diagnostics, Inc.||Metering tip with internal features to control fluid meniscus and oscillation|
|US20040217059 *||May 25, 2004||Nov 4, 2004||Bio/Data Corporation||Method and apparatus for directly sampling a fluid for microfiltration|
|US20050244912 *||Apr 30, 2004||Nov 3, 2005||Chong-Sheng Yuan||Methods for assaying inhibitors of S-adenosylhomocysteine (SAH) hydrolase and S-adenosylmethionine (SAM)-dependent methyltransferase|
|US20060060531 *||Aug 9, 2005||Mar 23, 2006||Bio/Data Corporation||Method and apparatus for directly sampling a fluid for microfiltration|
|US20060211038 *||May 23, 2006||Sep 21, 2006||Anthony Montgomery||Methods for detecting vasculopathies and tumors|
|US20110250105 *||Nov 9, 2009||Oct 13, 2011||Kunihiro Suto||Blood serum or blood plasma separating material and blood-collecting tube using same|
|CN102872616B||Sep 26, 2012||Oct 1, 2014||成都众睿达科技有限公司||一种血液分离胶及其制备方法|
|DE2743882A1 *||Sep 29, 1977||Mar 30, 1978||Nippon Paint Co Ltd||Trennmittel und verfahren zum auftrennen einer blutprobe in serum- oder plasma- und gerinnsel-anteile|
|DE2820706A1 *||May 11, 1978||Nov 16, 1978||Unilever Emery||Copolyesterzusammensetzung|
|EP0046391A1 *||Aug 14, 1981||Feb 24, 1982||Sekisui Kagaku Kogyo Kabushiki Kaisha||Composition for partitioning blood components|
|EP0705882A2||Sep 26, 1995||Apr 10, 1996||Becton Dickinson and Company||Blood compatible, shear sensitive formulations|
|EP1552267A2 *||May 13, 2003||Jul 13, 2005||Bayer Corporation||Serum transfer cup|
|WO2003099190A2 *||May 13, 2003||Dec 4, 2003||Bayer Ag||Serum transfer cup|
|WO2007095450A2 *||Feb 8, 2007||Aug 23, 2007||Peter Cronin||Improved gel compositions, apparatuses and fluid separation methods|
|U.S. Classification||494/37, 494/38, 422/73, 494/23, 436/17, 210/789|
|Feb 28, 1990||AS||Assignment|
Owner name: ORGANON TEKNIKA CORPORATION, A CORP. OF DE.
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:LUKACS AND JACOBY ASSOCIATES;REEL/FRAME:005251/0338
Effective date: 19890914
|Feb 28, 1990||AS02||Assignment of assignor's interest|
Owner name: LUKACS AND JACOBY ASSOCIATES
Effective date: 19890914
Owner name: ORGANON TEKNIKA CORPORATION, A CORP. OF DE.